The U.S. botanical extract market will maintain a 5.5%–9.2% compound annual growth rate (CAGR) from 2026 to 2034, and Chinese herbal extracts will remain the core imported botanical raw material category. Driven by the boom of preventive healthcare, adaptogen supplements, clean-label functional foods and clean beauty, application boundaries will break through traditional dietary supplements and expand to four high-growth tracks:

Mental & stress wellness: Astragalus, schisandra, reishi extracts for cortisol regulation, sleep improvement and cognitive support; adaptogenic Chinese herbs become mainstream alternatives to synthetic anti-anxiety ingredients.

Sports & metabolic nutrition: Berberine, codonopsis, salvia miltiorrhiza for blood sugar balance, athletic recovery and cardiovascular care, favored by fitness crowds and middle-aged groups.

Cosmeceuticals & ingestible beauty: Scutellaria, angelica sinensis, goji berry extracts added to anti-aging, anti-inflammatory skincare and oral beauty gummies; the clean beauty segment achieves double-digit annual growth for TCM plant extracts.

Functional food & beverage: Mild herbal extracts integrated into ready-to-drink shots, plant-based snacks and probiotic formulas, matching Americans’ demand for daily convenient wellness products.

Single-standardized extracts still take up over 50% market share, while compound herbal blends targeting multi-dimensional sub-health problems will grow faster at an 8.6% CAGR.